Workboat Indexes

Recent Quotes
My Watchlist
Indicators
Local Stocks
Markets
Workboat Indexes
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Kura Oncology, Inc. - Common Stock (NQ: KURA )

9.010 +0.040 (+0.45%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,204,000
Open 8.920
Bid (Size) 8.760 (1)
Ask (Size) 9.100 (1)
Prev. Close 8.970
Today's Range 8.880 - 9.170
52wk Range 8.850 - 24.17
Shares Outstanding 68,438,576
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Nasdaq Edges Higher; Baidu Shares Fall After Q3 Results
Via Benzinga

Performance

YTD
-41.34%
-41.34%
1 Month
-16.57%
-16.57%
3 Month
-55.42%
-55.42%
6 Month
-57.26%
-57.26%
1 Year
-35.69%
-35.69%

More News

Read More
Crude Oil Gains 1%; Deere Posts Better-Than-Expected Earnings
Via Benzinga
Exposures Fossil Fuels
Dow Jumps Over 100 Points; Nvidia Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
Kura Oncology Slams The Door On Its Takeover Narrative, And Shares Collapse 26%
Via Investor's Business Daily
2 Incredible Growth Stocks to Buy Hand Over Fist
Via The Motley Fool
Kura Oncology Inc. (NASDAQ: KURA) is a Stock Spotlight on 3/6
Via Investor Brand Network
Kura Oncology: Q4 Earnings Insights
Via Benzinga
Maximus Reports Weak Earnings, Joins Atkore, PDD Holdings And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Via Benzinga
This Caterpillar Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday
Via Benzinga
KURA Stock Earnings: Kura Oncology Beats EPS for Q2 2024
Via InvestorPlace
7 ‘Death Cross’ Stocks That Could Be Contrarian Buys
Via InvestorPlace
Acute Myeloid Leukemia is on the Rise as Biotechs Race to Develop Groundbreaking Therapies
Via FinancialNewsMedia
Acute Myeloid Leukemia is on the Rise as Biotechs Race to Develop Groundbreaking Therapies
From FN Media Group LLC
Via GlobeNewswire
KURA Stock Earnings: Kura Oncology Misses EPS for Q1 2024
Via InvestorPlace
Earnings Scheduled For February 27, 2024
Via Benzinga
Earnings Outlook For Kura Oncology
Via Benzinga
MAIA Biotechnology: Undervalued With Eye-Popping Cancer Data And Partnership Potential
Via Talk Markets
Kura Makes Good On Its $150 Million Infusion And Shoots Up Another 15%
Via Investor's Business Daily
Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Why Cancer-Drug Developer Kura Oncology Stock Is Up
Via Benzinga
General Motors Posts Upbeat Earnings, Joins Corning, HCA Healthcare And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Topics Stocks
Exposures US Equities
Dow Edges Lower; US Composite PMI Rises In January
Via Benzinga
Topics Stocks
Exposures US Equities
Why BlackBerry Shares Are Trading Lower By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Diversified Communications
© 2024 Diversified Communications. All rights reserved.